DMD

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Redondo, P. A.
Right arrow Articles by Prieto, J. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Redondo, P. A.
Right arrow Articles by Prieto, J. G.

Vol. 27, Issue 6, 736-740, June 1999

Presystemic Metabolism of Albendazole: Experimental Evidence of an Efflux Process of Albendazole Sulfoxide to Intestinal Lumen

P. A. Redondo, A. I. Álvarez, J. L. Garcia, O. M. Larrodé, G. Merino, and J. G. Prieto

Laboratory of Animal Physiology, Faculty of Veterinary, University of León, León, Spain

Albendazole (ABZ) presystemic clearance was studied in rat by perfusion of a 25 µM ABZ solution in isolated intestinal loops. Significant secretion of the active metabolite, ABZSO, into the lumen was observed. The metabolite was also present in mesenteric blood. After 30 min of intestinal perfusion, 64% of the ABZ dose had disappeared from lumen. The total amount of ABZSO measured was 0.341 ± 0.04 nmol/cm with 0.176 ± 0.03 nmol/cm in mesenteric blood. The metabolite secretion to intestinal lumen was 0.165 ± 0.05 nmol/cm. Intestinal sulfoxidation was induced by repeated administration of ABZ and ABZ coadministered with surfactants, especially polysorbate 80. The enantioselectivity of the in vitro intestinal sulfoxidation of ABZ showed that the relative contribution of P-450 and flavin-containing monooxygenase was quite similar, but after the induction by ABZ coadministered with polysorbate 80, the cytochrome P-450 system contribution was significantly increased. The appearance of ABZSO in mesenteric blood clearance was also increased under these conditions.


Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Am J Trop Med HygHome page
T. Junghanss, A. M. da Silva, J. Horton, P. L. Chiodini, and E. Brunetti
Clinical Management of Cystic Echinococcosis: State of the Art, Problems, and Perspectives
Am J Trop Med Hyg, September 1, 2008; 79(3): 301 - 311.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
G. Merino, J. W. Jonker, E. Wagenaar, M. M. Pulido, A. J. Molina, A. I. Alvarez, and A. H. Schinkel
TRANSPORT OF ANTHELMINTIC BENZIMIDAZOLE DRUGS BY BREAST CANCER RESISTANCE PROTEIN (BCRP/ABCG2)
Drug Metab. Dispos., May 1, 2005; 33(5): 614 - 618.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
G. Virkel, A. Lifschitz, J. Sallovitz, A. Pis, and C. Lanusse
COMPARATIVE HEPATIC AND EXTRAHEPATIC ENANTIOSELECTIVE SULFOXIDATION OF ALBENDAZOLE AND FENBENDAZOLE IN SHEEP AND CATTLE
Drug Metab. Dispos., May 1, 2004; 32(5): 536 - 544.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
G. Merino, A. I. Alvarez, J. G. Prieto, and R. B. Kim
The Anthelminthic Agent Albendazole Does Not Interact with P-Glycoprotein
Drug Metab. Dispos., April 1, 2002; 30(4): 365 - 369.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1999 by the American Society for Pharmacology and Experimental Therapeutics.